β-Methylfentanyl

β-Methylfentanyl is a synthetic opioid analgesic and a structural analogue of fentanyl. It was first identified in the early 1980s, where it appeared briefly on the illicit drug market before being controlled under Schedule I regulations. Like other fentanyl analogues, β-methylfentanyl acts as a potent agonist at opioid receptors, producing effects similar to fentanyl such as analgesia, euphoria, and potentially life-threatening respiratory depression. Its high potency and risk profile have led to its classification as having no accepted medical use in the United States and a high potential for abuse[1][3][5]. The mechanism of action involves binding primarily to the mu-opioid receptor (MOR), leading to inhibition of neurotransmitter release through G-protein coupled pathways[6][8]. There are no known legitimate pharmaceutical developers or manufacturers; production has been limited to clandestine laboratories.

Other names

BetamethylfentanylUNII-9658A8O6GKUNII9658A8O6GKUNII 9658A8O6GK